OTC "Drug Facts" Column Size Flexibility Sought By Industry
This article was originally published in The Tan Sheet
Executive Summary
The use of different size columns for multiple "Drug Facts" boxes on OTC labels would give manufacturers greater flexibility to include graphics within the box, industry trade groups tell FDA.
You may also be interested in...
OTC Drug Review’s Constitutionality Questioned By CHPA
FDA's OTC Drug Review could be challenged on constitutional grounds, the Consumer Healthcare Products Association states in Sept. 13 comments to the agency
OTC Drug Review’s Constitutionality Questioned By CHPA
FDA's OTC Drug Review could be challenged on constitutional grounds, the Consumer Healthcare Products Association states in Sept. 13 comments to the agency
OTC Drug Review’s Constitutionality Questioned By CHPA
FDA's OTC Drug Review could be challenged on constitutional grounds, the Consumer Healthcare Products Association states in Sept. 13 comments to the agency